STOCKNO.DE
Institutional ownership intelligence
Research
Schedule 13G/A

PDSB Schedule 13G/A filing by BlackRock

BlackRock reported beneficial ownership of 1.8M shares, representing 4.96% of PDS Biotechnology Corp in this filing.

FiledMay 8, 2024
Ownership dateApr 30, 2024
Reported shares1.8M
Reported ownership4.96%
Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 1.8M
Shared voting power 1.8M
Sole dispositive power 1.8M
Shared dispositive power 1.8M
Price context

Price dates alongside the ownership filing

Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.

Close near filing date$4.02as of May 8, 2024
Latest tracked price$0.72as of Aug 4, 2026
Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer
BlackRock
CIK
CIK0001364742
Accession
0001086364-24-007600
Form
Schedule 13G/A
Open SEC filing View PDSB ownership history
Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →